EMSA OF THE FUTURE

[Anonymous]

Imagine having Dr No and Dr asshole working together. Impossible?

A nightmare of epic proportions.

 

[Anonymous]

Agree that this so called Dr Craig Granowitz is a real messed up. He has never practiced medicine....worked all his professional career at Schering Plough....Hates Merck....thinks he is always right....lacks emotional IQ....treats us like shit.

Question to Ken Frasier, Adam Schechter and the Merck Board of Directors.


WHY DO WE HAVE TO PUT UP WITH SUCH A BULLY!

 

[Anonymous]

Agree that this so called Dr Craig Granowitz is a real messed up. He has never practiced medicine....worked all his professional career at Schering Plough....Hates Merck....thinks he is always right....lacks emotional IQ....treats us like shit.

Question to Ken Frasier, Adam Schechter and the Merck Board of Directors.


WHY DO WE HAVE TO PUT UP WITH SUCH A BULLY!

Let us know when Kenny, Adam and the rest of the gang get back to you with an answer.

 

[Anonymous]

Hey Sethu your pride is on the phone and your dignity left a message. They want to know when they can come back.

 

[Anonymous]

Don't pick on poor Sethu he is as defenseless as a baby seal and out of his league still turning to his daddy Richard for advice.

 

[Anonymous]

What kind of advice does King Richard impart? How to manage up effectively? How to cash a fat paycheck without adding value? Or just how to be an asshole in general?

 

[Anonymous]

Ummmmm........all of the above????

 

[Anonymous]

Can somebody wake Adam up?

 

[Anonymous]

Adam is busy managing upward and plotting how to get Ken out. Managing down has never been his strength. Just look at his record.

 

[Anonymous]

Adam is busy managing upward and plotting how to get Ken out. Managing down has never been his strength. Just look at his record.

Yes, Adam's impressive record include:
1. Pepcid Nominal price program as a product manager
2. Strategic Senior management roles:
-Zetia and Vytorin strategy for Enhance
-Vioxx before it imploded
-Point for Mrk/Schering merger
-Successful integration of the merger
-Consolidation of the 1 Merck management structure


A successful path to lead Mrk globally.

INDEED IMPRESSIVE RECORD!

 

[Anonymous]

Yes, Adam's impressive record include:
1. Pepcid Nominal price program as a product manager
2. Strategic Senior management roles:
-Zetia and Vytorin strategy for Enhance
-Vioxx before it imploded
-Point for Mrk/Schering merger
-Successful integration of the merger
-Consolidation of the 1 Merck management structure


A successful path to lead Mrk globally.

INDEED IMPRESSIVE RECORD!

Adam has done a Hell of a job handling Granny. Very impressive indeed!

 

[Anonymous]

Adam has done a Hell of a job handling Granny. Very impressive indeed!

I think u have a wrong read. It was meant to be a cynical remark reflecting that Adam has implemented very poorly and nothing to show for deliverables. All the projects reflect failures.

 

[Anonymous]

Adam is busy managing upward and plotting how to get Ken out. Managing down has never been his strength. Just look at his record.

Plotting to get Ken out? That explains a lot.

 

[Anonymous]

What kind of advice does King Richard impart? How to manage up effectively? How to cash a fat paycheck without adding value? Or just how to be an asshole in general?

You forgot how to game the system and being a legend in your own mind.

 

[Anonymous]

The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation
Robert M. Califf, Duke University Medical Center; Gary L. Filerman, Atlas Health Foundation; Richard K. Murray, Merck & Co., Inc.; and Michael Rosenblatt, Merck & Co., Inc.

How can these two Merck employees publish and talk about clinical trial enterprise and Disruptive Innovation for IOM with academical physicians?

Here is the problem.....Merck Clinical Research is to sell only their products and not to impact delivery of care. There is nothing disruptive about Merck research since their focus is solely their commercial . The design and control of every trial published by Merck is under the control of the commercial enterprise.

This is not the same Richard K. Murray in charge of EMSA?

How did Merck employees get to be on the IOM....surely there is a conflict?

 

[Anonymous]

The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation
Robert M. Califf, Duke University Medical Center; Gary L. Filerman, Atlas Health Foundation; Richard K. Murray, Merck & Co., Inc.; and Michael Rosenblatt, Merck & Co., Inc.

How can these two Merck employees publish and talk about clinical trial enterprise and Disruptive Innovation for IOM with academical physicians?

Here is the problem.....Merck Clinical Research is to sell only their products and not to impact delivery of care. There is nothing disruptive about Merck research since their focus is solely their commercial . The design and control of every trial published by Merck is under the control of the commercial enterprise.

This is not the same Richard K. Murray in charge of EMSA?

How did Merck employees get to be on the IOM....surely there is a conflict?

Clear example of collusion between Merck, IOM, and Academia.

 

[Anonymous]

I am just shocked Merck would participate in such collusion/conflict of interest. Especially with the CMO and RKM involved. People need to justify their existence and pay check somehow.

 

[Anonymous]

The Clinical Trials Enterprise in the United States: A Call for Disruptive Innovation
Robert M. Califf, Duke University Medical Center; Gary L. Filerman, Atlas Health Foundation; Richard K. Murray, Merck & Co., Inc.; and Michael Rosenblatt, Merck & Co., Inc.

How can these two Merck employees publish and talk about clinical trial enterprise and Disruptive Innovation for IOM with academical physicians?

Here is the problem.....Merck Clinical Research is to sell only their products and not to impact delivery of care. There is nothing disruptive about Merck research since their focus is solely their commercial . The design and control of every trial published by Merck is under the control of the commercial enterprise.

Maybe Merck needs to add these 10 dos to establish credibility

"Top 10 Recommendations for Closing the Credibility Gap in Reporting Industry-Sponsored Clinical Research
1.Ensure clinical studies and publications address clinically important questions

2.Make public all results, including negative or unfavorable ones, in a timely fashion, while avoiding redundancy

3.Improve understanding and disclosure of authors' potential conflicts of interest

4.Educate authors on how to develop quality manuscripts and meet journal expectations

5.Improve disclosure of authorship contributions and writing assistance and continue education on best publication practices to end ghostwriting and guest authorship

6.Report adverse event data more transparently and in a more clinically meaningful manner

7.Provide access to more complete protocol information

8.Transparently report statistical methods used in analysis

9.Ensure authors can access complete study data, know how to do so, and can attest to this

10.Support the sharing of prior reviews from other journals"

 

[Anonymous]

You forgot one:

11. Get rid of that lazy unethical pos Dr. Richard K. Murray. That would be a good start towards regaining credibility.

 

[Anonymous]

This whole thread just exeplifies the failure of leadership which permeates all aspects and divisions. Everyone needs to wake up. I am waiting for the academic papers on effectively managing up, looking out for number one, and harnessing your inner narcissist to get ahead. Those are the only topics these bozos can comment on with any credibility.